13-Methyltetradecanoic acid(Synonyms: 13-MTD; 13-Methylmyristic acid)

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。

13-Methyltetradecanoic acid (Synonyms: 13-MTD; 13-Methylmyristic acid)

13-Methyltetradecanoic acid (13-MTD),一种具有强效抗癌作用的饱和支链脂肪酸。13-Methyltetradecanoic acid 在多种类型的人类癌细胞中诱导细胞凋亡 (apoptosis)。

13-Methyltetradecanoic acid(Synonyms: 13-MTD;  13-Methylmyristic acid)

13-Methyltetradecanoic acid Chemical Structure

CAS No. : 2485-71-4

规格 是否有货
5 mg 询价
10 mg 询价
25 mg 询价

* Please select Quantity before adding items.

生物活性

13-Methyltetradecanoic acid (13-MTD), a saturated branched-chain fatty acid with potent anticancer effects. 13-Methyltetradecanoic acid induces apoptosis in many types of human cancer cells[1][2].

体外研究
(In Vitro)

13-Methyltetradecanoic acid (13-MTD; 0-140 μg/mL; 12-24 hours) inhibits cell viability and proliferation in human bladder cancer cells by inducing apoptosis[1].
13-Methyltetradecanoic acid (13-MTD; 70 μg/mL; 2-48 hours) treatments results in significant accumulation of cells with sub-G1 DNA content in a time-dependent manner, with the proportion of sub-G1 phase DNA content ranging from 9.25% to 85.3% over 2-48 hours[1].
13-Methyltetradecanoic acid (13-MTD; 70 μg/mL; 2-24 hours) down-regulates Bcl-2 and up-regulates Bax. This promotes mitochondrial dysfunction, leading to the release of cytochrome c from the mitochondria to the cytoplasm, as well as the proteolytic activation of caspases. 13-Methyltetradecanoic acid down-regulates AKT phosphorylation and activates phosphorylation of p38 and c-Jun N-terminal kinase (JNK)[1].

上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay[1]

Cell Line: Bladder cancer cell lines T24, 5637, and UM-UC-3
Concentration: 0 μg/mL, 35 μg/mL, 70 μg/mL, 105 μg/mL, and 140 μg/mL
Incubation Time: 12 hours, 24 hours
Result: Inhibition of cell viability in a dose- and time-dependent manner.

Cell Cycle Analysis[1]

Cell Line: Bladder cancer cell lines T24, 5637, and UM-UC-3
Concentration: 70 μg/mL
Incubation Time: 2 hours, 8 hours, 24 hours, or 48 hours
Result: Resulted in significant accumulation of cells with sub-G1 DNA content in a time-dependent manner.

Western Blot Analysis[1]

Cell Line: T24, 5637, and UM-UC-3 cells
Concentration: 70 μg/mL
Incubation Time: 2 hours, 8 hours, 24 hours
Result: Down-regulated Bcl-2 and up-regulated Bax, and down-regulated AKT phosphorylation and activated phosphorylation of p38 and c-Jun N-terminal kinase (JNK).

体内研究
(In Vivo)

13-Methyltetradecanoic acid (13-MTD; 70 mg/kg/day; oral gavage; daily; for 30 days) significantly suppresses tumor growth in a xenograft model[2].

上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: BALB/C nude mice injected with Jurkat lymphoma cells[2]
Dosage: 70 mg/kg/day
Administration: Oral gavage; daily; for 30 days
Result: Effectively inhibited the growth in vivo in a xenograft model.

分子量

242.40

Formula

C15H30O2

CAS 号

2485-71-4

中文名称

13-甲基十四烷酸

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

参考文献
  • [1]. Tianxin Lin, et al. 13-Methyltetradecanoic acid induces mitochondrial-mediated apoptosis in human bladder cancer cells. Urol Oncol. May-Jun 2012;30(3):339-45.

    [2]. Qingqing Cai, et al. 13-methyltetradecanoic acid exhibits anti-tumor activity on T-cell lymphomas in vitro and in vivo by down-regulating p-AKT and activating caspase-3. PLoS One. 2013 Jun 7;8(6):e65308.

所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务